Cite
Huang X, Cao M, Wu S, et al. Anti-leukemia activity of NSC-743380 in SULT1A1-expressing acute myeloid leukemia cells is associated with inhibitions of cFLIP expression and PI3K/AKT/mTOR activities. Oncotarget. 2017;8(60):102150-102160doi: 10.18632/oncotarget.22235.
Huang, X., Cao, M., Wu, S., Wang, L., Hu, J., Mehran, R. J., Roth, J. A., Swisher, S. G., Wang, R. Y., Kantarjian, H. M., Andreeff, M., Sun, X., & Fang, B. (2017). Anti-leukemia activity of NSC-743380 in SULT1A1-expressing acute myeloid leukemia cells is associated with inhibitions of cFLIP expression and PI3K/AKT/mTOR activities. Oncotarget, 8(60), 102150-102160. https://doi.org/10.18632/oncotarget.22235
Huang, Xiao, et al. "Anti-leukemia activity of NSC-743380 in SULT1A1-expressing acute myeloid leukemia cells is associated with inhibitions of cFLIP expression and PI3K/AKT/mTOR activities." Oncotarget vol. 8,60 (2017): 102150-102160. doi: https://doi.org/10.18632/oncotarget.22235
Huang X, Cao M, Wu S, Wang L, Hu J, Mehran RJ, Roth JA, Swisher SG, Wang RY, Kantarjian HM, Andreeff M, Sun X, Fang B. Anti-leukemia activity of NSC-743380 in SULT1A1-expressing acute myeloid leukemia cells is associated with inhibitions of cFLIP expression and PI3K/AKT/mTOR activities. Oncotarget. 2017 Nov 01;8(60):102150-102160. doi: 10.18632/oncotarget.22235. eCollection 2017 Nov 24. PMID: 29254232; PMCID: PMC5731942.
Copy
Download .nbib